Maxigen Biotech Correlations

1783 Stock  TWD 52.70  1.90  3.74%   
The current 90-days correlation between Maxigen Biotech and Great China Metal is -0.09 (i.e., Good diversification). The correlation of Maxigen Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
  
The ability to find closely correlated positions to Maxigen Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Maxigen Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Maxigen Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Maxigen Biotech to buy it.

Moving against Maxigen Stock

  0.732072 Century Wind PowerPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
23293094
80862434
23294510
23299905
30949905
99054510
  
High negative correlations   
24349905
24343094
80869905
23292434
24342379
24344510

Risk-Adjusted Indicators

There is a big difference between Maxigen Stock performing well and Maxigen Biotech Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Maxigen Biotech's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Maxigen Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Piotroski F Score Now

   

Piotroski F Score

Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
All  Next Launch Module

Maxigen Biotech Corporate Management

Elected by the shareholders, the Maxigen Biotech's board of directors comprises two types of representatives: Maxigen Biotech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Maxigen. The board's role is to monitor Maxigen Biotech's management team and ensure that shareholders' interests are well served. Maxigen Biotech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Maxigen Biotech's outside directors are responsible for providing unbiased perspectives on the board's policies.